NEW BRUNSWICK, N.J.
April 23, 2013
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceuticals business for the Investment Community beginning at
8:30 a.m. (Eastern Time)
Thursday, May 23, 2013
at the Hyatt Regency Hotel in
New Brunswick, New Jersey
and ending at approximately
, M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific Officer and
, Worldwide Chairman, Pharmaceuticals will host the meeting. The meeting will also feature presentations from the therapeutic area leaders within the Pharmaceuticals Research and Development organization.
The agenda for the day will be posted on the Investor Relations website on approximately
Investors and other interested parties may access this meeting by visiting the Company's website at
for a simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live webcast through
SOURCE Johnson & Johnson